Dermata Therapeutics, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−20.2893 USD
−12.29 M USD
0.00 USD
1.66 M
About Dermata Therapeutics, Inc.
Sector
Industry
CEO
Gerald T. Proehl
Website
Headquarters
San Diego
Founded
2014
Identifiers
3
ISIN US2498451168
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.